Literature DB >> 14640946

Biologic strategies for the therapy of intervertebral disc degeneration.

Helen E Gruber1, Edward N Hanley.   

Abstract

Recent advances in tissue engineering have led to promising new approaches for the biologic treatment of disc degeneration. At present, there is no effective therapy for disc degeneration, a condition which results in large healthcare and socio-economic costs. This article will examine the current approaches used in biologic therapies for disc degeneration, including cell-based tissue engineering, gene therapy and the application of mesenchymal stem cells, and discuss their therapeutic potential, as demonstrated in animal models and experimental studies to date.

Entities:  

Mesh:

Year:  2003        PMID: 14640946     DOI: 10.1517/14712598.3.8.1209

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  19 in total

1.  Surgical pinealectomy accelerates intervertebral disc degeneration process in chicken.

Authors:  Mehmet Turgut; Hatice K Başaloğlu; Ciğdem Yenisey; Yelda Ozsunar
Journal:  Eur Spine J       Date:  2005-09-07       Impact factor: 3.134

Review 2.  Scaffolding in tissue engineering: general approaches and tissue-specific considerations.

Authors:  B P Chan; K W Leong
Journal:  Eur Spine J       Date:  2008-11-13       Impact factor: 3.134

3.  Silk-fibrin/hyaluronic acid composite gels for nucleus pulposus tissue regeneration.

Authors:  Sang-Hyug Park; Hongsik Cho; Eun Seok Gil; Biman B Mandal; Byoung-Hyun Min; David L Kaplan
Journal:  Tissue Eng Part A       Date:  2011-08-23       Impact factor: 3.845

Review 4.  Molecular therapy of the intervertebral disc.

Authors:  S Tim Yoon; Nilpesh M Patel
Journal:  Eur Spine J       Date:  2006-07-12       Impact factor: 3.134

5.  SIRT1 inhibits apoptosis of degenerative human disc nucleus pulposus cells through activation of Akt pathway.

Authors:  DaWu Wang; ZhenMing Hu; Jie Hao; Bin He; Qiang Gan; XiaoMing Zhong; XiaoJun Zhang; JieLiang Shen; Ji Fang; Wei Jiang
Journal:  Age (Dordr)       Date:  2012-09-19

6.  Experimental study on self-assembly of KLD-12 peptide hydrogel and 3-D culture of MSC encapsulated within hydrogel in vitro.

Authors:  Jianhua Sun; Qixin Zheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-08-07

7.  Meta-analysis of the effects of genetic polymorphisms on intervertebral disc degeneration.

Authors:  J Rigal; A Léglise; T Barnetche; A Cogniet; S Aunoble; J C Le Huec
Journal:  Eur Spine J       Date:  2017-05-27       Impact factor: 3.134

8.  Biocompatibility of KLD-12 peptide hydrogel as a scaffold in tissue engineering of intervertebral discs in rabbits.

Authors:  Jianhua Sun; Qixin Zheng; Yongchao Wu; Yudong Liu; Xiaodong Guo; Weigang Wu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-04-21

9.  Exogenous thymosin beta4 prevents apoptosis in human intervertebral annulus cells in vitro.

Authors:  H Tapp; R Deepe; J A Ingram; E G Yarmola; M R Bubb; E N Hanley; H E Gruber
Journal:  Biotech Histochem       Date:  2009-12       Impact factor: 1.718

10.  Do we need biomarkers for disc degeneration?

Authors:  Helen E Gruber; Edward N Hanley
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.